T. Patterson

发表

Oocytes from Xenopus laevis contain an intrinsic σ 2-like binding site

S. Appleyard, C. Chavkin, M. Connor, 1994, Neuroscience Letters.

In vitro and in vivo characterization of 3-[2-[6-(2-tert-butoxyethoxy)pyridin-3-yl]-1H-imidazol-4-yl]benzonitrile hydrochloride salt, a potent and selective NPY5 receptor antagonist.

T. Maurer, D. Hargrove, C. Mack, 2003, Journal of medicinal chemistry.

Rotating disk voltammetric measurements in neurobiology and neuropharmacology

J. O. Schenk, T. Patterson, J. S. Mcelvain, 1990 .

Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans.

S. Watkins, Tara B. Manion, Dawn Mather, 2013, American journal of physiology. Gastrointestinal and liver physiology.

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.

P. Elliott, C. Rapezzi, M. Maurer, 2020, JACC. Heart failure.

Oocytes from Xenopus laevis contain an intrinsic sigma 2-like binding site.

S. Appleyard, C. Chavkin, M. Connor, 1994, Neuroscience letters.

Causes of Cardiovascular Hospitalization and Death in Patients with Transthyretin Amyloid Cardiomyopathy (From the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]).

J. López-Sendón, J. Januzzi, Alan Miller, 2021, The American journal of cardiology.

Food intake in rhesus monkeys following central administration of orexins

J. Kemnitz, Wendy Newton, A. Swick, 2005, Regulatory Peptides.

Agonist‐Induced Phosphorylation of the κ‐Opioid Receptor

S. Appleyard, C. Chavkin, T. Patterson, 1997 .

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Sanjiv J. Shah, D. Judge, P. Elliott, 2018, The New England journal of medicine.

The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers

M. O’Gorman, P A Lockwood, Ekaterina Tankisheva, 2020, Clinical pharmacology in drug development.

Neuroendocrine Correlates of Food Intake and Diabetes

D. Figlewicz, M. Brot, P. Szot, 1998 .

Effects of acute and chronic systemic administration of some typical antipsychotic drugs on turnover of dopamine and potassium ion-induced release of dopamine in the striatum of the rat in vivo

J. O. Schenk, T. Patterson, 1991, Neuropharmacology.

Discovery and evaluation of spirocyclic derivatives as antagonists of the neuropeptide Y5 receptor.

Peter Cornelius, Eunsun Lee, D. Scott, 2012, Bioorganic & medicinal chemistry letters.

Immunocytochemical localization of delta opioid receptors in mouse brain

S. Appleyard, C. Chavkin, S. Bausch, 1995, Journal of Chemical Neuroanatomy.

Kappa opioid receptor‐like immunoreactivity in guinea pig brain: Ultrastructural localization in presynaptic terminals in hippocampal formation

C. Drake, C. Chavkin, T. Milner, 1996, The Journal of comparative neurology.

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

P. Seymour, J. Siuciak, P. Iredale, 2007, Neuropharmacology.

Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study

D. Judge, P. García-Pavía, G. Merlini, 2020, European journal of heart failure.

Impact of Tafamidis on Health-Related Quality of Life in Patients with Transthyretin Amyloid Cardiomyopathy (From the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).

M. Maurer, M. Stewart, T. Damy, 2020, The American journal of cardiology.

Dopamine transporter mRNA is increased in the CNS of Zucker fatty (fa/fa) rats

D. Figlewicz, P. Szot, T. Patterson, 1998, Brain Research Bulletin.

D2 Receptors May Modulate the Function of the Striatal Transporter for Dopamine: Kinetic Evidence from Studies In Vitro and In Vivo

J. O. Schenk, S. M. Meiergerd, S M Meiergerd, 1993, Journal of neurochemistry.

Food Deprivation Decreases mRNA and Activity of the Rat Dopamine Transporter

D. Figlewicz, M. Brot, P. Szot, 1998, Neuroendocrinology.

Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity.

K. Liu, B. Lefker, Janice A. Brown, 2010, Bioorganic & medicinal chemistry letters.

Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.

T. Maurer, K. Liu, Janice A. Brown, 2010, Bioorganic & medicinal chemistry letters.

Neurotransmitter Transporters: Target for Endocrine Regulation

D. Figlewicz, M. Brot, P. Szot, 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Sodium depletion and aldosterone decrease dopamine transporter activity in nucleus accumbens but not striatum.

M. Roitman, D. Figlewicz, I. Bernstein, 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

Evaluation of a Mathematical Model of Rat Body Weight Regulation in Application to Caloric Restriction and Drug Treatment Studies

Jangir Selimkhanov, T. Maurer, D. Scott, 2016, PloS one.

Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics.

Peter Cornelius, Eunsun Lee, Dennis E Danley, 2003, Bioorganic & medicinal chemistry letters.

Colocalization of mu opioid receptors with GIRK1 potassium channels in the rat brain: an immunocytochemical study.

H. Lester, N. Davidson, M. Ehrengruber, 1995, Receptors & channels.